Canada markets closed

Vaxil Bio Ltd. (VXLLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0050-0.0003 (-5.66%)
At close: 11:38AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 999.75k
Enterprise Value 263.33k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.16
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.57

Trading Information

Stock Price History

Beta (5Y Monthly) -3.58
52-Week Change 3-63.95%
S&P500 52-Week Change 322.64%
52 Week High 30.0600
52 Week Low 30.0021
50-Day Moving Average 30.0113
200-Day Moving Average 30.0123

Share Statistics

Avg Vol (3 month) 350.27k
Avg Vol (10 day) 326.14k
Shares Outstanding 5136.98M
Implied Shares Outstanding 6200.52M
Float 8125.69M
% Held by Insiders 18.16%
% Held by Institutions 10.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.67%
Return on Equity (ttm)-41.91%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -456.5k
Net Income Avi to Common (ttm)-453k
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.01M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.53
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-675k
Levered Free Cash Flow (ttm)-501.25k